Agitation

Neurology·MeSH: Psychomotor Agitation

6 drugs in development·6 companies·3 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)

Phase 3(3)

Drug	Company
avp-786	NYMOX PHARMACEUTICAL CORP (NYMXF)
AXS-05	Axsome Therapeutics, Inc. (AXSM)
bxcl501	BioXcel Therapeutics, Inc. (BTAI)

Phase 2(1)

Drug	Company
ITI-1284-ODT-SL	Intra-Cellular Therapies, Inc. (ITCI)

Phase 4(1)

Drug	Company
xanomeline/trospium	BRISTOL MYERS SQUIBB CO (BMY)

BioSniper tracks 6 drugs in development for Agitation across 6 companies.

There are 3 clinical trials targeting Agitation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.